Prescription Drugs

State (Maine)
Maine 132nd Legislature

An Act to Clarify the Requirements for Accessing Nonformulary Drugs and Drugs Used to Treat Serious Mental Illness [SB-1100]
An Act to Clarify the Requirements for Accessing Nonformulary Drugs and Drugs Used to Treat Serious Mental Illness

  

Sponsored by: Sen. Donna Bailey Received By The Secretary Of The Senate On March 14, 2025 And Referred To The Committee On Health Coverage, Insurance And Financial Services Pursuant To Joint Rule 308.2 on 03/14/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Ensure That Rebates from Prescription Drug Manufacturers Are Passed on to Patients at Pharmacies [HB-1053]
An Act to Ensure That Rebates from Prescription Drug Manufacturers Are Passed on to Patients at Pharmacies

  

Sponsored by: Sen. Nicole Grohoski Received By The Clerk Of The House On March 12, 2025. on 03/12/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Protect Health Care for Rural and Underserved Areas by Prohibiting Discrimination by Participants in a Federal Drug Discount Program [SB-1018]
An Act to Protect Health Care for Rural and Underserved Areas by Prohibiting Discrimination by Participants in a Federal Drug Discount Program

  

Sponsored by: Sen. Matthea Larsen Daughtry Received By The Secretary Of The Senate On March 12, 2025 And Referred To The Committee On Health Coverage, Insurance And Financial Services Pursuant To Joint Rule 308.2 on 03/12/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Idaho)
Idaho 2025 Regular Session

Adds to existing law to establish provisions regarding certain prohibited actions by pharmaceutical manufacturers. [HB-385]
PRESCRIPTION DRUGS -- Adds to existing law to establish provisions regarding certain prohibited actions by pharmaceutical manufacturers.

  

Sponsored by: Rep. Reported Printed And Referred To Health & Welfare on 03/10/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Permit the Dispensing of Ivermectin Pursuant to a Standing Order upon Request for COVID-19, Flu and Cancer Patients [SB-890]
An Act to Permit the Dispensing of Ivermectin Pursuant to a Standing Order upon Request for COVID-19, Flu and Cancer Patients

  

Sponsored by: Sen. Jeffrey Timberlake Committee On Health Coverage, Insurance And Financial Services Suggested And Ordered Printed Reference To The Committee On Health Coverage, Insurance And Financial Services Ordered Sent Down Forthwith For Concurrence on 03/04/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Amend the Laws Governing the Controlled Substances Prescription Monitoring Program [HB-765]
An Act to Amend the Laws Governing the Controlled Substances Prescription Monitoring Program

  

Sponsored by: Rep. Michele Meyer Committee On Health And Human Services Suggested And Ordered Printed. on 02/25/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing [SB-697]
An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing

  

Sponsored by: Sen. Donna Bailey Received By The Secretary Of The Senate On February 20, 2025 And Referred To The Committee On Health Coverage, Insurance And Financial Services Pursuant To Joint Rule 308.2 on 02/20/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives [HB-538]
An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives

  

Sponsored by: Rep. Ryan Fecteau Committee On Health Coverage, Insurance And Financial Services Suggested And Ordered Printed. on 02/11/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Arizona)
Arizona Fifty-seventh Legislature - First Regular Session (2025)

Prescription drugs; price limits [SB-1403]
Prescription drugs; price limits

  

Sponsored by: Sen. Lela Alston Senate Read Second Time on 02/04/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Arizona)
Arizona Fifty-seventh Legislature - First Regular Session (2025)

Essential drugs; price increases; limits. [SB-1402]
Essential drugs; price increases; limits.

  

Sponsored by: Sen. Lela Alston Senate Read Second Time on 02/04/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Prescription Drugs. [SB-1509]
Requires the Legislative Reference Bureau to conduct a study on best practices for the regulation of pharmacy benefit managers and reduction in prescription drug costs for health insurance plan beneficiaries. Requires a report to the Legislature. Effective 12/31/2050. (HD1)

  

Sponsored by: Sen. Ronald Kouchi Bill Scheduled To Be Heard By Cpc On Wednesday, 03-19-25 2:00pm In House Conference Room 329 Via Videoconference. on 03/14/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Health. [HB-712]
Prohibits drug manufacturers from denying, restricting, or prohibiting the acquisition, shipping, or delivery of a 340B drug to pharmacies contracted with 340B covered entities under the federal 340B Drug Pricing Program. Authorizes the 340B covered entity and Attorney General to bring a civil action for enforcement. Specifies a four-year limitations period for bringing an action. Effective 7/1/3000. (HD2)

  

Sponsored by: Rep. Gregg Takayama The Committee(s) On Hhs/cpn Has Rescheduled Its Public Hearing To 03-19-25 9:30am; Cr 229 & Videoconference. on 03/14/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Health. [SB-480]
Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.

  

Sponsored by: Sen. Joy San Buenaventura The Committee On Hhs Deferred The Measure. on 02/10/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Allow Retail Pharmacies to Operate Remote Dispensing Sites in Rural Areas [SB-239]
An Act to Allow Retail Pharmacies to Operate Remote Dispensing Sites in Rural Areas

  

Sponsored by: Sen. Bradlee Farrin Work Session Held: Tabled on 02/27/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Prescription Drugs. [HB-216]
Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.

  

Sponsored by: Rep. Gregg Takayama Referred To Hlt, Cpc, Fin, Referral Sheet 1 on 01/21/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Prescription Drugs. [SB-226]
Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.

  

Sponsored by: Sen. Lynn Decoite Referred To Hhs, Cpn. on 01/17/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act Regarding the Interactions of Pharmacy Benefits Managers and So-called 340B Entities and Reimbursements by Pharmacy Benefits Managers to Pharmacies [HB-180]
An Act Regarding the Interactions of Pharmacy Benefits Managers and So-called 340B Entities and Reimbursements by Pharmacy Benefits Managers to Pharmacies

  

Sponsored by: Rep. Kristi Mathieson Committee On Health Coverage, Insurance And Financial Services Suggested And Ordered Printed. on 01/14/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 131st Legislature

An Act to Provide Greater Transparency About the Cost of Insulin and to Promote the Availability of Low-cost Insulin in the State [SB-2282]
An Act to Provide Greater Transparency About the Cost of Insulin and to Promote the Availability of Low-cost Insulin in the State

  

Sponsored by: No sponsors Passed To Be Enacted, In Concurrence. on 04/03/2024

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Idaho)
Idaho 2024 Regular Session

Adds to existing law to establish equitable billing practices for 340B drugs and covered entities. [HB-671]
PRESCRIPTION DRUGS -- Adds to existing law to establish equitable billing practices for 340B drugs and covered entities.

  

Sponsored by: Rep. Reported Printed And Referred To Health & Welfare on 02/28/2024

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Arizona)
Arizona Fifty-sixth Legislature - Second Regular Session (2024)

Prescription drugs; price limits [SB-1532]
Prescription drugs; price limits

  

Sponsored by: Sen. Lela Alston Senate Read Second Time on 02/06/2024

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0